Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Valve Prosthesis Implantation | 13 | 2021 | 164 | 2.120 |
Why?
|
| Mitral Valve | 10 | 2021 | 166 | 2.000 |
Why?
|
| Heart Valve Prosthesis | 12 | 2021 | 222 | 1.930 |
Why?
|
| Transcatheter Aortic Valve Replacement | 6 | 2021 | 90 | 1.590 |
Why?
|
| Aortic Valve | 6 | 2021 | 249 | 1.330 |
Why?
|
| Heart Transplantation | 5 | 2020 | 328 | 1.010 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 4 | 2017 | 9 | 0.960 |
Why?
|
| Cardiac Catheterization | 7 | 2019 | 419 | 0.920 |
Why?
|
| Heart-Assist Devices | 7 | 2021 | 221 | 0.790 |
Why?
|
| Amiodarone | 2 | 2020 | 21 | 0.750 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 696 | 0.750 |
Why?
|
| Heart Failure | 7 | 2021 | 1180 | 0.720 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2020 | 98 | 0.710 |
Why?
|
| Stents | 8 | 2021 | 657 | 0.700 |
Why?
|
| Heart Valve Diseases | 3 | 2016 | 123 | 0.650 |
Why?
|
| Ventricular Function, Left | 3 | 2017 | 481 | 0.640 |
Why?
|
| Prosthesis Design | 11 | 2018 | 301 | 0.610 |
Why?
|
| Embolism | 1 | 2017 | 45 | 0.580 |
Why?
|
| Aortic Valve Stenosis | 4 | 2021 | 177 | 0.570 |
Why?
|
| Coronary Artery Bypass | 1 | 2017 | 218 | 0.550 |
Why?
|
| Device Removal | 1 | 2017 | 100 | 0.540 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2021 | 99 | 0.530 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 277 | 0.500 |
Why?
|
| Ventricular Function, Right | 3 | 2021 | 103 | 0.480 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2014 | 59 | 0.480 |
Why?
|
| Echocardiography, Transesophageal | 9 | 2016 | 100 | 0.450 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2017 | 450 | 0.420 |
Why?
|
| Microscopy, Video | 1 | 2012 | 27 | 0.410 |
Why?
|
| Minimally Invasive Surgical Procedures | 5 | 2021 | 85 | 0.390 |
Why?
|
| Treatment Outcome | 14 | 2021 | 7029 | 0.380 |
Why?
|
| Regeneration | 1 | 2012 | 105 | 0.380 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 261 | 0.380 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 164 | 0.370 |
Why?
|
| Graft Survival | 2 | 2020 | 465 | 0.370 |
Why?
|
| Bioprosthesis | 1 | 2010 | 101 | 0.330 |
Why?
|
| Retrospective Studies | 15 | 2021 | 7277 | 0.330 |
Why?
|
| Neovascularization, Pathologic | 5 | 2003 | 183 | 0.330 |
Why?
|
| Postoperative Complications | 7 | 2019 | 1615 | 0.320 |
Why?
|
| Veterans | 1 | 2016 | 904 | 0.320 |
Why?
|
| Heart Ventricles | 3 | 2019 | 738 | 0.310 |
Why?
|
| Prosthesis Implantation | 3 | 2015 | 83 | 0.310 |
Why?
|
| Middle Aged | 18 | 2021 | 21147 | 0.310 |
Why?
|
| Aged | 13 | 2021 | 14862 | 0.280 |
Why?
|
| Female | 21 | 2021 | 38074 | 0.280 |
Why?
|
| Registries | 2 | 2021 | 733 | 0.280 |
Why?
|
| Survival Rate | 7 | 2019 | 1056 | 0.260 |
Why?
|
| Swine | 6 | 2021 | 672 | 0.250 |
Why?
|
| Humans | 31 | 2021 | 68618 | 0.250 |
Why?
|
| Animals | 18 | 2021 | 20881 | 0.240 |
Why?
|
| Coronary Stenosis | 1 | 2007 | 246 | 0.240 |
Why?
|
| Atrial Fibrillation | 1 | 2007 | 249 | 0.240 |
Why?
|
| Hemodynamics | 7 | 2014 | 705 | 0.240 |
Why?
|
| Time Factors | 5 | 2017 | 4655 | 0.230 |
Why?
|
| Postoperative Care | 2 | 2015 | 163 | 0.230 |
Why?
|
| Male | 20 | 2021 | 37321 | 0.220 |
Why?
|
| Sus scrofa | 4 | 2012 | 74 | 0.220 |
Why?
|
| Length of Stay | 5 | 2021 | 780 | 0.210 |
Why?
|
| Adenocarcinoma | 4 | 2002 | 475 | 0.210 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 792 | 0.190 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 49 | 0.190 |
Why?
|
| Thoracic Surgery | 1 | 2021 | 72 | 0.180 |
Why?
|
| Wisconsin | 2 | 2016 | 31 | 0.170 |
Why?
|
| Metalloendopeptidases | 1 | 1999 | 67 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 536 | 0.160 |
Why?
|
| Patient Acuity | 2 | 2020 | 17 | 0.160 |
Why?
|
| Protease Inhibitors | 1 | 1999 | 76 | 0.160 |
Why?
|
| Pulmonary Ventilation | 1 | 2018 | 28 | 0.160 |
Why?
|
| Vascular Resistance | 1 | 2019 | 179 | 0.160 |
Why?
|
| Hydroxamic Acids | 1 | 1999 | 84 | 0.160 |
Why?
|
| Glycine | 1 | 1999 | 89 | 0.160 |
Why?
|
| Stroke Volume | 2 | 2019 | 586 | 0.160 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2017 | 250 | 0.160 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2018 | 102 | 0.150 |
Why?
|
| Heart Arrest, Induced | 1 | 2017 | 52 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 4 | 2003 | 332 | 0.150 |
Why?
|
| Patient Selection | 3 | 2016 | 592 | 0.150 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 323 | 0.140 |
Why?
|
| Recovery of Function | 2 | 2017 | 506 | 0.140 |
Why?
|
| Colonic Neoplasms | 1 | 1999 | 299 | 0.140 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2017 | 117 | 0.140 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 1173 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2017 | 110 | 0.140 |
Why?
|
| Propensity Score | 3 | 2021 | 117 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 772 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 532 | 0.130 |
Why?
|
| Benchmarking | 1 | 2016 | 91 | 0.130 |
Why?
|
| Risk Factors | 4 | 2021 | 5731 | 0.130 |
Why?
|
| Hospitals, Veterans | 1 | 2016 | 147 | 0.130 |
Why?
|
| Patient Readmission | 2 | 2015 | 267 | 0.130 |
Why?
|
| Ileus | 1 | 2015 | 7 | 0.130 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 567 | 0.130 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2016 | 134 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 1851 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2016 | 2358 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2016 | 275 | 0.120 |
Why?
|
| Hospital Units | 1 | 2014 | 21 | 0.120 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2014 | 36 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2018 | 2324 | 0.110 |
Why?
|
| Alloys | 2 | 2012 | 66 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 2 | 2011 | 119 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2014 | 453 | 0.100 |
Why?
|
| Side-Population Cells | 1 | 2012 | 1 | 0.100 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2012 | 12 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 4848 | 0.100 |
Why?
|
| Sequence Deletion | 1 | 2012 | 89 | 0.100 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 84 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 200 | 0.100 |
Why?
|
| Equipment Design | 2 | 2012 | 500 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1140 | 0.100 |
Why?
|
| Heart Atria | 1 | 2012 | 206 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2012 | 396 | 0.090 |
Why?
|
| Tricuspid Valve | 1 | 2011 | 42 | 0.090 |
Why?
|
| Mice | 7 | 2012 | 8474 | 0.090 |
Why?
|
| Adult | 6 | 2021 | 21403 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2011 | 652 | 0.090 |
Why?
|
| Myocardial Contraction | 1 | 2012 | 383 | 0.090 |
Why?
|
| Sternotomy | 1 | 2010 | 18 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 940 | 0.090 |
Why?
|
| Fixatives | 1 | 2010 | 24 | 0.090 |
Why?
|
| Glutaral | 1 | 2010 | 41 | 0.090 |
Why?
|
| Foreign-Body Migration | 1 | 2010 | 38 | 0.090 |
Why?
|
| Pulmonary Valve | 1 | 2010 | 40 | 0.090 |
Why?
|
| Interleukin-12 | 2 | 2000 | 75 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 130 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 1033 | 0.080 |
Why?
|
| Catheterization | 1 | 2010 | 209 | 0.080 |
Why?
|
| Myocardium | 1 | 2012 | 1204 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 2791 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2002 | 64 | 0.060 |
Why?
|
| Age Factors | 2 | 2020 | 1864 | 0.050 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2003 | 11 | 0.050 |
Why?
|
| Neoplasm Transplantation | 2 | 2000 | 160 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3259 | 0.050 |
Why?
|
| Angiogenic Proteins | 1 | 2002 | 5 | 0.050 |
Why?
|
| Neoplasm Metastasis | 2 | 2003 | 306 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2002 | 41 | 0.050 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2021 | 19 | 0.050 |
Why?
|
| Hospital Charges | 1 | 2021 | 60 | 0.050 |
Why?
|
| Pancreas | 1 | 2003 | 225 | 0.050 |
Why?
|
| Florida | 1 | 2021 | 221 | 0.050 |
Why?
|
| Pneumonectomy | 1 | 2021 | 79 | 0.050 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2021 | 20 | 0.050 |
Why?
|
| Technology | 1 | 2021 | 24 | 0.050 |
Why?
|
| Incidence | 2 | 2015 | 1603 | 0.050 |
Why?
|
| Mice, SCID | 4 | 2003 | 238 | 0.050 |
Why?
|
| Acute Disease | 2 | 2019 | 658 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2000 | 118 | 0.040 |
Why?
|
| Models, Animal | 2 | 2011 | 252 | 0.040 |
Why?
|
| Elasticity | 1 | 2019 | 103 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 265 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 622 | 0.040 |
Why?
|
| Proteins | 1 | 2002 | 474 | 0.040 |
Why?
|
| Observer Variation | 1 | 2018 | 330 | 0.040 |
Why?
|
| Lung | 1 | 2021 | 849 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 515 | 0.030 |
Why?
|
| Pancreatitis | 1 | 1998 | 279 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 373 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 2002 | 852 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 193 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2014 | 33 | 0.030 |
Why?
|
| Perioperative Nursing | 1 | 2014 | 3 | 0.030 |
Why?
|
| Radiography | 1 | 2014 | 572 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2077 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2014 | 384 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2014 | 344 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 1038 | 0.020 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2011 | 36 | 0.020 |
Why?
|
| Comorbidity | 1 | 2015 | 1426 | 0.020 |
Why?
|
| Transfection | 2 | 2002 | 782 | 0.020 |
Why?
|
| Polymers | 1 | 2011 | 244 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2012 | 1034 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1174 | 0.020 |
Why?
|
| United States | 1 | 2019 | 7367 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 1046 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2009 | 458 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2550 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2003 | 29 | 0.010 |
Why?
|
| Heme Oxygenase-1 | 1 | 2003 | 40 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2003 | 147 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2002 | 122 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 492 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 541 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2002 | 167 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 710 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1174 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2000 | 124 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1664 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 617 | 0.010 |
Why?
|
| Amylases | 1 | 1998 | 17 | 0.010 |
Why?
|
| Japan | 1 | 1998 | 68 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 5717 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1998 | 125 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1998 | 91 | 0.010 |
Why?
|
| Adolescent | 1 | 2009 | 8912 | 0.010 |
Why?
|
| Cytokines | 1 | 2000 | 866 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1998 | 446 | 0.010 |
Why?
|
| Prognosis | 1 | 1998 | 2093 | 0.010 |
Why?
|